Related Experiment Video
Updated: Apr 19, 2026
07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
9.6K
Nanoparticles applied to antineoplastic agents: a patent landscape
Iolanda M Fierro1, Maria Simone de Menezes Alencar, Flavia Maria Lins Mendes
1National Institute of Industrial Property (INPI-Brazil), Mayrink Veiga, 9 Centro, 20090-910, Rio de Janeiro, Brazil.
Pharmaceutical Patent Analyst
|December 10, 2014
Summary
Cancer nanotechnology is advancing with novel nanoparticle treatments. Patent analysis reveals polymers and proteins are key innovation areas for cancer therapy development.
Area of Science:
- Nanomedicine
- Biotechnology
- Materials Science
Background:
- Cancer poses a significant global health burden.
- Nanoparticles offer promising therapeutic strategies for cancer treatment.
- Existing cancer therapies face challenges that nanotechnology aims to address.
Purpose of the Study:
- To analyze patenting trends in cancer nanotechnology.
- To identify key innovation areas and applicants in nanoparticle-based cancer treatments.
- To understand the focus of research and development in this field.
Main Methods:
- Review of patents filed over the last 14 years.
- Identification of patents granted in the last four years.
- Analysis of focus areas of major patent applicants.
Main Results:
- Patenting activity in cancer nanotechnology has shown notable progress.
- Polymers and proteins are identified as primary targets in patented nanoparticle systems.
- Innovative efforts are concentrated on these materials for cancer treatment applications.
Conclusions:
- Patenting trends indicate significant advancements in cancer nanotechnology.
- Polymers and proteins represent key areas for future innovation in nanoparticle-based cancer therapies.
- Patent analysis serves as a valuable indicator for tracking progress in the field.
